Nitroaspirin
- Generic Name
- Nitroaspirin
- Drug Type
- Small Molecule
- Chemical Formula
- C16H13NO7
- CAS Number
- 175033-36-0
- Unique Ingredient Identifier
- EH04H13L6B
- Background
Nitroaspirin has been investigated for the treatment of Intermittent Claudication.
Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
- First Posted Date
- 2010-12-09
- Last Posted Date
- 2011-01-19
- Lead Sponsor
- NicOx Research Institute S.r.l.
- Target Recruit Count
- 442
- Registration Number
- NCT01256775
- Locations
- 🇮🇹
Ospedale di Perugia, Perugia, Italy
Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy
Phase 2
Terminated
- Conditions
- Type 2 DiabetesEarly Nephropathy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Mario Negri Institute for Pharmacological Research
- Target Recruit Count
- 13
- Registration Number
- NCT00157508
- Locations
- 🇮🇹
Clinical Research Center for Rare Diseases, Ranica, Bergamo, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath